Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

34.09 -0.30 (-0.87%)
Streaming Delayed Price Updated: 11:55 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 Next >
Immunocore (IMCR) Q2 Revenue Jumps 30%
Via The Motley Fool
Topics Earnings Intellectual Property
Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor... 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews
 
Via Benzinga
Analyst Expectations For Immunocore Holdings's Future
 
Via Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
What Analysts Are Saying About Immunocore Hldgs Stock
 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
Analyst Expectations For Immunocore Hldgs's Future
 
Via Benzinga
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks. 
Via Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches. 
Via MarketBeat
Navigating 8 Analyst Ratings For Immunocore Hldgs
 
Via Benzinga
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
 
Via Benzinga
Analyst Ratings For Immunocore Hldgs
 
Via Benzinga
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Analyst Expectations For Immunocore Hldgs's Future
 
Via Benzinga
The Latest Analyst Ratings For Immunocore Hldgs
 
Via Benzinga
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
 
Via Benzinga
3 Small-Cap Stocks with Significant Growth Potential
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love. 
Via InvestorPlace
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
 
Via Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
 
Via Benzinga
Analyst Expectations For Immunocore Hldgs's Future
 
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
 
Via Benzinga
Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
 
Via Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024
IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. 
Via InvestorPlace
Key Takeaways From Immunocore Hldgs Analyst Ratings
 
Via Benzinga
Immunocore Hldgs's Earnings: A Preview
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.